A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 150 KRW 2.84% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Depreciation & Amortization
â‚©3.2B
CAGR 3-Years
19%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Depreciation & Amortization
â‚©412.3B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
19%
SK Bioscience Co Ltd
KRX:302440
Depreciation & Amortization
â‚©34.8B
CAGR 3-Years
28%
CAGR 5-Years
39%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Depreciation & Amortization
â‚©16.1B
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Depreciation & Amortization
â‚©12.8B
CAGR 3-Years
11%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Depreciation & Amortization
â‚©2.9B
CAGR 3-Years
12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Depreciation & Amortization?
Depreciation & Amortization
3.2B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Depreciation & Amortization amounts to 3.2B KRW.

What is ABL Bio Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
45%

Over the last year, the Depreciation & Amortization growth was 47%. The average annual Depreciation & Amortization growth rates for ABL Bio Inc have been 19% over the past three years , 45% over the past five years .

Back to Top